Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06939257 · ClinicalTrials.gov registry record
The Impact of Gender Affirming Hormone Therapy on Pain In Gender Minority Adults
A clinical trial of Pain and Gender Minority Individuals, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06939257 is a study of Pain and Gender Minority Individuals that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 200 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06939257, a study of Pain and Gender Minority Individuals, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
TRANSPIRE is an observational study of \~200 individuals who (1) will be initiating gender-affirming hormone therapy (GHT) or (2) are gender minority individuals who do not use GHT. The primary outcome will be to identify how the presence of chronic pain changes overtime with GHT through the use of surveys, quantitative sensory testing (QST), brain MRIs, and qualitative interviews. Following recruitment and consent, participants will complete baseline survey measures and will repeat those measures at 1 months, 3 month, 6 months, and 12 months. QST measures, brain MRIs, and Qualitative Interviews will be offered to participants in cohort (1) and will be completed at baseline and 12 months.
Conditions Studied
Study Locations (1)
Kansas
- The University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-03-31 |
| Est. Completion | 2029-09-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06939257
The ClinicalTrials.gov registry entry for NCT06939257 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (34% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 0 interventions.
NCT06939257 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT06939257 about?
NCT06939257 is a clinical study titled "The Impact of Gender Affirming Hormone Therapy on Pain In Gender Minority Adults". TRANSPIRE is an observational study of \~200 individuals who (1) will be initiating gender-affirming hormone therapy (GHT) or (2) are gender minority individuals who do not use GHT. The primary outcome will be to identify how the presence of chronic pain changes overtime with GHT through the use of ...
What is the current status of trial NCT06939257?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-03-31. Estimated completion is 2029-09-16.
What conditions does trial NCT06939257 study?
This clinical trial studies the following conditions: Pain, Gender Minority Individuals.
Who is sponsoring clinical trial NCT06939257?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06939257 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.